Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Uppi
AddedFeb 18, 2024
UpdatedJun 18, 2026
Uppi

Uppi

Angel

UPPI: Leading nuclear medicine & PET pharmacy network since 1998, enhancing industry professionalism.

HQ
Suwanee, GA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Founded in 1998, UPPI is a prominent network in the nuclear medicine and PET pharmacy sectors. The organization aims to enhance the professionalism of the industry by offering its members national strength in purchasing relationships and access to customizable local programs. UPPI represents over 80 independent and institutional operating sites across the United States, focusing on providing high-quality services and products in nuclear and PET pharmacy.

UPPI's network includes notable professionals and institutions that contribute to its reputation and success. The organization has achieved significant milestones in expanding its reach and influence within the industry. By fostering strong buying relationships and offering tailored programs, UPPI has made a substantial impact on the nuclear medicine and PET pharmacy landscape, supporting advancements and professional growth within the field.

Uppi - Similar Companies

Partners Pharmacy logo

Partners Pharmacy

Nucleus RadioPharma logo

Nucleus RadioPharma

nucleusrad.com

NuScriptRx logo

NuScriptRx

nuscriptrx.com

Caring Pharmacy logo

Caring Pharmacy

Pharmacy Development logo

Pharmacy Development

Pharma Nation logo

Pharma Nation

pharmanation.com

Pinpoint Pharma logo

Pinpoint Pharma

pinpointpharma.co

Apothecary Solutions logo

Apothecary Solutions

Urogpo logo

Urogpo

Remedi SeniorCare logo

Remedi SeniorCare

remedirx.com

RxNetwork logo

RxNetwork

Apothecary Products logo

Apothecary Products

Upmc logo

Upmc

Village Fertility Pharmacy logo

Village Fertility Pharmacy

Peak Rx #2 logo

Peak Rx #2

Uppi - Quick Facts

Who are Uppi's competitors?

Companies similar to Uppi include Partners Pharmacy, Nucleus RadioPharma, NuScriptRx and Caring Pharmacy.

When was Uppi founded?

Uppi was founded in 1998.

Where is Uppi's headquarters located?

Uppi's headquarters is located in Suwanee, GA, US.

When was Uppi's last funding round?

Uppi's most recent funding round was for $105k (USD) in April 2011.

How much has Uppi raised to-date?

As of Apr 5, 2011, Uppi has raised a total of $105k (USD).

How many employees does Uppi have?

Uppi has 7 employees as of Feb 4, 2024.

Uppi - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Nuclear Medicine
  • Pharmacy Network
Tags
  • Network
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research